SE416543B - Sibstituerat cyklopentanderivat till anvendning som mellanprodukt vid framstellning av farmaceutiskt aktiva prostaglandinanaloger - Google Patents

Sibstituerat cyklopentanderivat till anvendning som mellanprodukt vid framstellning av farmaceutiskt aktiva prostaglandinanaloger

Info

Publication number
SE416543B
SE416543B SE7304635A SE7304635A SE416543B SE 416543 B SE416543 B SE 416543B SE 7304635 A SE7304635 A SE 7304635A SE 7304635 A SE7304635 A SE 7304635A SE 416543 B SE416543 B SE 416543B
Authority
SE
Sweden
Prior art keywords
sibstituted
cyclopentand
derivatives
preparation
pharmaceutically active
Prior art date
Application number
SE7304635A
Other languages
English (en)
Swedish (sv)
Inventor
T K Schaaf
E J Corey
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE416543B publication Critical patent/SE416543B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
SE7304635A 1972-04-17 1973-04-02 Sibstituerat cyklopentanderivat till anvendning som mellanprodukt vid framstellning av farmaceutiskt aktiva prostaglandinanaloger SE416543B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US244882A US3887587A (en) 1972-04-17 1972-04-17 Synthesis of prostaglandins of the one-series

Publications (1)

Publication Number Publication Date
SE416543B true SE416543B (sv) 1981-01-19

Family

ID=22924496

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7304635A SE416543B (sv) 1972-04-17 1973-04-02 Sibstituerat cyklopentanderivat till anvendning som mellanprodukt vid framstellning av farmaceutiskt aktiva prostaglandinanaloger
SE7609048A SE7609048L (sv) 1972-04-17 1976-08-12 Forfarande for framstellning av prostaglandiner
SE7908125A SE7908125L (sv) 1972-04-17 1979-10-01 Forfarande for framstellning av prostaglandiner
SE7908126A SE7908126L (sv) 1972-04-17 1979-10-01 Forfarande for framstellning av prostaglandiner

Family Applications After (3)

Application Number Title Priority Date Filing Date
SE7609048A SE7609048L (sv) 1972-04-17 1976-08-12 Forfarande for framstellning av prostaglandiner
SE7908125A SE7908125L (sv) 1972-04-17 1979-10-01 Forfarande for framstellning av prostaglandiner
SE7908126A SE7908126L (sv) 1972-04-17 1979-10-01 Forfarande for framstellning av prostaglandiner

Country Status (19)

Country Link
US (1) US3887587A (pl)
JP (1) JPS5710104B2 (pl)
AR (2) AR197135A1 (pl)
AT (1) AT336809B (pl)
AU (1) AU470252B2 (pl)
BE (1) BE798316A (pl)
CA (1) CA999579A (pl)
CH (2) CH568264A5 (pl)
DE (1) DE2319017C3 (pl)
ES (2) ES413786A1 (pl)
FR (3) FR2183711B1 (pl)
GB (4) GB1424417A (pl)
IE (2) IE37495B1 (pl)
NL (1) NL160250C (pl)
PL (2) PL103097B1 (pl)
SE (4) SE416543B (pl)
SU (1) SU580834A3 (pl)
YU (1) YU36924B (pl)
ZA (1) ZA732385B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243595A (en) * 1972-07-13 1981-01-06 Pfizer Inc. 15-Substituted-omega-pentanorprostaglandins
GB1432950A (en) * 1972-11-10 1976-04-22 Ici Ltd Cyclopentane aldehydes as chemical intermediates
US4737590A (en) * 1973-04-27 1988-04-12 American Cyanamid Company Novel 2-substituted-3,4-epoxycyclopentan-1-ones, 2-substituted-3,4-epoxycyclopentan-1-ols, and various 2-substituted-cyclopentenones
US4012431A (en) * 1973-05-21 1977-03-15 The Upjohn Company Process for preparing 5-oxa PGF1.sub.α -type compounds
US4060540A (en) * 1975-09-18 1977-11-29 American Cyanamid Company Novel 3-triphenylmethoxy-1-alkynes, 3-triphenyl-methoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
US4039574A (en) * 1975-09-25 1977-08-02 American Cyanamid Company 13-Hydroxy-15-deoxy-prostaglandins
US4219483A (en) * 1978-09-11 1980-08-26 Pfizer Inc. 4-Pyrone prostaglandin antagonists
JPH0964603A (ja) * 1995-08-26 1997-03-07 Nec Corp 温度補償型位相遅延回路
CN103570599B (zh) * 2013-11-11 2015-05-06 陕西大生制药科技有限公司 前列腺素a1的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA959485A (en) * 1970-05-04 1974-12-17 Gordon L. Bundy 15-alkyl prostaglandins
US3736335A (en) * 1970-06-22 1973-05-29 Merck & Co Inc Prostaglandins and methods of making same
DE2145125A1 (de) * 1970-09-11 1972-04-06 The Upjohn Co , Kalamazoo, Mich (V St A) Prostansaurederivate und deren Her stellung
CA951723A (en) * 1970-09-19 1974-07-23 Takashi Yusa Prostaglandin derivatives and process for the preparation thereof
GB1356581A (en) * 1970-10-09 1974-06-12 Ici Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
AT336809B (de) 1977-05-25
DE2319017B2 (de) 1978-06-08
CH578497A5 (pl) 1976-08-13
PL103097B1 (pl) 1979-05-31
SE7609048L (sv) 1976-08-12
PL196152A1 (pl) 1978-01-02
CH568264A5 (pl) 1975-10-31
ATA341273A (de) 1976-09-15
FR2275473A1 (fr) 1976-01-16
FR2275473B1 (pl) 1979-06-15
GB1424415A (en) 1976-02-11
SE7908125L (sv) 1979-10-01
IE37495L (en) 1973-10-17
ES413786A1 (es) 1977-05-01
AU470252B2 (en) 1976-03-11
FR2183711B1 (pl) 1978-06-30
GB1424417A (en) 1976-02-11
NL160250C (nl) 1979-10-15
YU103373A (en) 1982-06-18
DE2319017C3 (de) 1979-02-01
JPS5710104B2 (pl) 1982-02-24
AR197135A1 (es) 1974-03-15
IE37496B1 (en) 1977-08-03
PL99374B1 (pl) 1978-07-31
AU5428273A (en) 1974-10-10
ZA732385B (en) 1974-01-30
GB1424414A (en) 1976-02-11
JPS4914446A (pl) 1974-02-07
CA999579A (en) 1976-11-09
FR2275453B1 (pl) 1978-06-30
NL7305292A (pl) 1973-10-19
SE7908126L (sv) 1979-10-01
GB1424416A (en) 1976-02-11
US3887587A (en) 1975-06-03
SU580834A3 (ru) 1977-11-15
FR2275453A1 (fr) 1976-01-16
FR2183711A1 (pl) 1973-12-21
ES444110A1 (es) 1977-04-16
YU36924B (en) 1984-08-31
DE2319017A1 (de) 1973-10-31
NL160250B (nl) 1979-05-15
BE798316A (fr) 1973-10-17
AR204713A1 (es) 1976-02-27
IE37495B1 (en) 1977-08-03

Similar Documents

Publication Publication Date Title
SE400280B (sv) 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE444809B (sv) Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar
SE435289B (sv) O-substituerade 7 beta-amino-3-cefem-3-ol-4-karbonsyraderivat till anvendning som mellanprodukt for framstellning av o-substituerade 7 beta-acylamino-3-cefem-3-ol-4-karbonsyraderivat
SE409460B (sv) Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
SE431756B (sv) Fenoxi-2-oxopropylfosfonat till anvendning som mellanprodukt vid framstellning av nya w-pentanorprostaglandiner
SE417957B (sv) Omega-substituerade prostaglandinanaloger till anvendning som antifertilitetsmedel
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE388851B (sv) L-asparylaminomalonsyraalkylfenkyldiestrar och fysiologiskt godtagbara salter derav till anvendning som sotningsmedel
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE416543B (sv) Sibstituerat cyklopentanderivat till anvendning som mellanprodukt vid framstellning av farmaceutiskt aktiva prostaglandinanaloger
AR212858A1 (es) Procedimiento para la preparacion de derivados farmaceuticamente activos fenipolieno carboxilicos
NO138728C (no) Kinoksalin-di-n-oksyd derivater for anvendelse som vektsfremmende fortilsetningsmidler
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE383877B (sv) Anvendning av prostansyraderivat av pgf-typ som aktiva komponenter for framstellning av medel for forhindrande av graviditet
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
SE7611466L (sv) Mellanforening till anvendning vid framstellning av en ny d-2-substituerad-6-metyl-8-substituerad ergolin
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE402290B (sv) Forfarande for framstellning av tri-substituerade imidazoler avsedda att anvendas som anti-hyperuricemiska medel vid gikt
NO142624C (no) Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater
NO141121C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive morfolinderivater
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat